Letter to the Editor
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Virol. Mar 25, 2023; 12(2): 132-135
Published online Mar 25, 2023. doi: 10.5501/wjv.v12.i2.132
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
Ali Osman Gulmez, Sonay Aydin
Ali Osman Gulmez, Department of Radiology, Erzincan University, Erzincan 24100, Turkey
Sonay Aydin, Department of Radiology, Erzincan University, Erzincan 24100, Turkey
Author contributions: Aydin S and Gulmez AO conceived the study; Aydin S and Gulmez AO were responsible for designing, materials and supervision; Aydin S and Gulmez AO did the literature search, wrote the manuscript, and reviewed the manuscript critically; All authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ali Osman Gulmez, MD, Academic Research, Department of Radiology, Erzincan University, Mengucek Gazi Education and Research Hospital, Başbağlar Mahallesi Hacı Ali Akın Caddesi No. 32 Erzincan/Merkez, Erzincan 24100, Turkey. aliosmangulmez.2@gmail.com
Received: October 19, 2022
Peer-review started: October 19, 2022
First decision: November 22, 2022
Revised: November 30, 2022
Accepted: January 5, 2023
Article in press: January 5, 2023
Published online: March 25, 2023
Core Tip

Core Tip: Recommends biomarkers, especially troponin, in patients with Coronavirus disease-19-associated myocarditis and other myocardial damage; however, they have proven that in addition to traditional biomarkers, new cardiac bioenzymes such as prepesin, copeptin also increase and significantly worsen the prognosis. Knowing this, evaluation together with other imaging methods is also important in diagnosis.